tiprankstipranks
Perspective Therapeutics price target lowered to $9 from $17 at B. Riley
PremiumThe FlyPerspective Therapeutics price target lowered to $9 from $17 at B. Riley
3M ago
Perspective Therapeutics price target lowered to $16 from $25 at RBC Capital
Premium
The Fly
Perspective Therapeutics price target lowered to $16 from $25 at RBC Capital
3M ago
Perspective Therapeutics downgraded to Neutral from Buy at BofA
Premium
The Fly
Perspective Therapeutics downgraded to Neutral from Buy at BofA
3M ago
Perspective Therapeutics to pursue dose escalation in Phase 1/2a clinical trial
PremiumThe FlyPerspective Therapeutics to pursue dose escalation in Phase 1/2a clinical trial
3M ago
Perspective Therapeutics Reports Strong Cash Position and Clinical Advances
Premium
Company Announcements
Perspective Therapeutics Reports Strong Cash Position and Clinical Advances
3M ago
Is CATX a Buy, Before Earnings?
Premium
Pre-Earnings
Is CATX a Buy, Before Earnings?
3M ago
Perspective Therapeutics presents updates at 37th Annual Congress of EANM
PremiumThe FlyPerspective Therapeutics presents updates at 37th Annual Congress of EANM
4M ago
Perspective begins shipping investigational products from facility in NJ
Premium
The Fly
Perspective begins shipping investigational products from facility in NJ
4M ago
Tesla lower after ‘underwhelming’ robotaxi launch event: Morning Buzz
Premium
The Fly
Tesla lower after ‘underwhelming’ robotaxi launch event: Morning Buzz
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100